73 studies found for:    (celiac disease) [CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Condition: Celiac Disease
Intervention:
2 Completed Safety and Efficacy of Varying Methods of ALV003 Administration for the Treatment of Celiac Disease
Condition: Celiac Disease
Interventions: Biological: ALV003;   Biological: ALV003 placebo
3 Completed Safety and Efficacy of ALV003 for the Treatment of Celiac Disease
Condition: Celiac Disease
Interventions: Biological: ALV003;   Biological: ALV003 placebo
4 Completed HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease
Conditions: Celiac Disease;   Gluten
Intervention: Dietary Supplement: Gluten challenge.
5 Completed Safety Study of Nexvax2 in Subjects With Coeliac Disease
Conditions: Coeliac Disease;   Celiac Disease
Interventions: Biological: 9 micrograms Nexvax2;   Biological: 30 micrograms Nexvax2;   Biological: 90 micrograms Nexvax2;   Biological: 60 micrograms Nexvax2;   Biological: Up to 900 micrograms Nexvax2;   Other: Placebo
6 Active, not recruiting A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
Condition: Celiac Disease
Interventions: Drug: Larazotide Acetate 0.5 mg;   Drug: Larazotide Acetate 1 mg;   Drug: Larazotide Acetate 2 mg;   Drug: placebo
7 Recruiting Screen-detected Coeliac Disease, a Population Based Study
Condition: Celiac Disease
Intervention: Other: Gluten-free diet
8 Completed Effect of Aspergillus Niger Prolyl Endoprotease (AN-PEP) Enzyme on the Effects of Gluten Ingestion in Patients With Coeliac Disease
Condition: Celiac Disease
Interventions: Dietary Supplement: Aspergillus niger prolyl endoprotease;   Dietary Supplement: Placebo
9 Recruiting Gluten-free Diet in Gluten-genetically Predisposed Subjects
Conditions: Genetic Predisposition to Disease;   Celiac Disease
Intervention: Dietary Supplement: Gluten-free diet
10 Completed Performance Evaluation of Capsule Endoscopy in the Diagnosis of Gluten Sensitive Enteropathy (MA-23)
Condition: Celiac Disease
Intervention: Device: Capsule Endoscopy
11 Completed Treatment of Mild Enteropathy Celiac Disease
Condition: Celiac Disease
Intervention: Dietary Supplement: Gluten-free diet
12 Recruiting Dietary Intervention and Evaluation Trial (CD-DIET)
Conditions: Celiac Disease;   Diabetes Mellitus, Type 1
Intervention: Dietary Supplement: Gluten Free Diet
13 Terminated Response to Hepatitis B Vaccine in Celiac Disease Patients
Condition: Celiac Disease
Intervention: Biological: hepatitis B vaccine (EngerixB)
14 Unknown  Study of Enzyme Supplements to Treat Celiac Disease
Conditions: Celiac Disease;   Dermatitis Herpetiformis
Interventions: Drug: STAN1;   Drug: Placebo enzyme;   Drug: STAN1+gluten
15 Completed Gluten-Free Diet in Patients With Gluten Sensitivity and Cerebellar Ataxia
Conditions: Celiac Disease;   Cerebellar Ataxia;   Healthy
Intervention:
16 Completed Gut Peptides and Intestinal Permeability in Celiac Disease and Irritable Bowel Syndrome
Conditions: Celiac Disease;   Irritable Bowel Syndrome
Intervention:
17 Recruiting Assessing Neurocognitive Effects of Gluten Exposure
Conditions: Celiac Disease;   Neurobehavioral Manifestations
Interventions: Dietary Supplement: gluten;   Dietary Supplement: Placebo
18 Completed Treatment of Screen-detected Celiac Disease
Condition: Celiac Disease
Intervention: Dietary Supplement: Gluten-free diet
19 Completed Protocol for Correlating Enteropathic Severity and Small Intestinal CYP3A4 Activity in Patients With Celiac Disease
Condition: Celiac Disease
Intervention: Drug: Simvastatin
20 Completed Study of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Gluten-Containing Meal
Condition: Celiac Disease
Interventions: Drug: ALV003;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years